RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE: Pelareorep + Paclitaxel = ADC/HER2 failed breast cancerShould read : " .... and in a basic way explain how ONCY's pelareorep is also able to remodel the TME and overcome T-cell resistance and T-cell exhaustion."